Evidence map›Paper›PMID 34707778›Full record

ArticleOxidative medicine and cellular longevity2021

Botanical Drug Puerarin Ameliorates Liposaccharide-Induced Depressive Behaviors in Mice via Inhibiting RagA/mTOR/p70S6K Pathways.

Jia Zhao, Yizhen Jia, Wei Zhao, Huixin Chen, Xiuying Zhang, Fung Yin Ngo, Dan Luo, Youqiang Song, Lixing Lao, Jianhui Rong

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jia ZhaoDepartment of Chinese Medicine, The University of Hong Kong Shenzhen Hospital, Shenzhen, China.ORCID https://orcid.org/0000-0002-5082-6893
Yizhen JiaDepartment of Chinese Medicine, The University of Hong Kong Shenzhen Hospital, Shenzhen, China.
Wei ZhaoSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.ORCID https://orcid.org/0000-0002-0750-3132
Huixin ChenSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.
Xiuying ZhangSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.
Fung Yin NgoSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.
Dan LuoSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.
Youqiang SongSchool of Biomedical Science, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China.ORCID https://orcid.org/0000-0001-9407-2256
Lixing LaoSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.ORCID https://orcid.org/0000-0003-0198-9714
Jianhui RongSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.ORCID https://orcid.org/0000-0002-3709-7315
University of Hong Kong · HKChinese University of Hong Kong · HKCity University of Hong Kong, Shenzhen Research Institute · CNUniversity of Hong Kong - Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe depressive symptom hallmarks the progression of the neurodegenerative diseases, especially Alzheimer's disease. Bacterial infection is related to inflammation and depression. The present project thereby examined whether botanical drug puerarin could attenuate liposaccharide- (LPS-) induced depressive behaviors in mice.

methodsAdult male C57BL/6N mice were sequentially treated with LPS and puerarin and evaluated for the depressive behaviors by tail suspension test and forced swim test. The brain tissues were profiled for the molecular targets of puerarin by next-generation RNA sequencing technique. Candidate targets were further verified in LPS-treated mice, neural stem cells, and highly differentiated PC12 cell line.

resultsPuerarin ameliorated LPS-induced depression in the mice. RNA sequencing profiles revealed that puerarin altered the expression of 16 genes while markedly downregulated Ras-related GTP-binding protein A (RagA) in LPS-treated mice. The effect of puerarin on RagA expression was confirmed by immunostaining, Western blot, and quantitative real-time PCR (qRT-PCR). Biochemical studies showed that puerarin inhibited RagA/mTOR/p70S6K pathway, attenuated the accumulation of mTORC1 in close proximity to lysosome, and reduced the production of proinflammatory cytokines.

conclusionsBotanical drug puerarin attenuated inflammation and depressive behaviors in LPS-challenged mice by inhibiting RagA/mTOR/p70S6K pathways. Puerarin may be a lead compound for the new antidepressant drugs.

Indexed as

AnimalsAntidepressive AgentsBehavior, AnimalBrainCytokinesDepressionDisease Models, AnimalInflammation MediatorsIsoflavonesLipopolysaccharidesMaleMechanistic Target of Rapamycin Complex 1MiceMice, Inbred C57BLMonomeric GTP-Binding ProteinsNeural Stem CellsAntidepressive AgentsCytokinesInflammation MediatorsIsoflavonesLipopolysaccharidesMechanistic Target of Rapamycin Complex 1Monomeric GTP-Binding ProteinsmTOR protein, mousepuerarinRibosomal Protein S6 Kinases, 70-kDaRraga protein, MouseTOR Serine-Threonine Kinases

Identifiers

PMID34707778
PMCPMC8545548
OpenAlexW3205967753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.